Compare Cadila Healthcare with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE TORRENT PHARMA CADILA HEALTHCARE/
TORRENT PHARMA
 
P/E (TTM) x 17.2 42.2 40.7% View Chart
P/BV x 3.1 9.2 34.0% View Chart
Dividend Yield % 0.9 1.1 79.9%  

Financials

 CADILA HEALTHCARE   TORRENT PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-21
TORRENT PHARMA
Mar-21
CADILA HEALTHCARE/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs5093,040 16.8%   
Low Rs2591,933 13.4%   
Sales per share (Unadj.) Rs147.5473.0 31.2%  
Earnings per share (Unadj.) Rs20.974.0 28.2%  
Cash flow per share (Unadj.) Rs28.0112.9 24.8%  
Dividends per share (Unadj.) Rs3.5035.00 10.0%  
Avg Dividend yield %0.91.4 64.8%  
Book value per share (Unadj.) Rs126.9344.9 36.8%  
Shares outstanding (eoy) m1,023.74169.22 605.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.65.3 49.5%   
Avg P/E ratio x18.433.6 54.7%  
P/CF ratio (eoy) x13.722.0 62.3%  
Price / Book Value ratio x3.07.2 42.0%  
Dividend payout %16.847.3 35.4%   
Avg Mkt Cap Rs m393,092420,798 93.4%   
No. of employees `000NANA-   
Total wages/salary Rs m22,54814,396 156.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m151,02280,048 188.7%  
Other income Rs m449757 59.3%   
Total revenues Rs m151,47180,806 187.5%   
Gross profit Rs m31,33524,666 127.0%  
Depreciation Rs m7,2486,578 110.2%   
Interest Rs m1,6883,583 47.1%   
Profit before tax Rs m22,84815,263 149.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4722,744 53.6%   
Profit after tax Rs m21,37612,519 170.8%  
Gross profit margin %20.730.8 67.3%  
Effective tax rate %6.418.0 35.8%   
Net profit margin %14.215.6 90.5%  
BALANCE SHEET DATA
Current assets Rs m87,16055,232 157.8%   
Current liabilities Rs m78,61348,916 160.7%   
Net working cap to sales %5.77.9 71.7%  
Current ratio x1.11.1 98.2%  
Inventory Days Days3314 231.9%  
Debtors Days Days767 1,088.1%  
Net fixed assets Rs m140,94381,298 173.4%   
Share capital Rs m1,024846 121.0%   
"Free" reserves Rs m128,89957,526 224.1%   
Net worth Rs m129,92358,372 222.6%   
Long term debt Rs m6,09529,633 20.6%   
Total assets Rs m228,103136,530 167.1%  
Interest coverage x14.55.3 276.3%   
Debt to equity ratio x00.5 9.2%  
Sales to assets ratio x0.70.6 112.9%   
Return on assets %10.111.8 85.7%  
Return on equity %16.521.4 76.7%  
Return on capital %18.021.4 84.2%  
Exports to sales %00-   
Imports to sales %10.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,911NA-   
Fx inflow Rs m63,53521,539 295.0%   
Fx outflow Rs m15,9117,136 223.0%   
Net fx Rs m47,62414,403 330.6%   
CASH FLOW
From Operations Rs m32,93020,107 163.8%  
From Investments Rs m-7,225-4,494 160.8%  
From Financial Activity Rs m-25,489-16,561 153.9%  
Net Cashflow Rs m-905-893 101.4%  

Share Holding

Indian Promoters % 74.9 71.3 105.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.7 20.6 76.1%  
FIIs % 3.8 11.6 32.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 28.8 87.4%  
Shareholders   370,931 67,205 551.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

SGX Nifty Tanks 294 Points, Maruti Suzuki Quarterly Results, Oyo's Rs 84 bn IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note on Tuesday. Benchmark indices snapped their five-day losing run and ended on a positive note in a highly volatile session.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 35.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 35.0% YoY). Sales on the other hand came in at Rs 40 bn (up 14.5% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of CADILA HEALTHCARE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Torrent Pharma Beats Expectations: Stock Gets a Boost (Views On News)

May 19, 2021

Key takeaways from Torrent Pharma's March quarter results.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 25, 2022 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS